Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05845671 |
|---|---|
| Brief Title: | Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations |
| First Submitted : | April 25, 2023 |
| First Submitted that Met QC Criteria : | April 25, 2023 |
| First Posted : | May 6, 2023 |
| Last Update Submitted that Met QC Criteria : | May 10, 2024 |
| Last Update Posted : | May 13, 2024 |